Systematic review of the performance of HIV viral load technologies on plasma samples.
<h4>Background</h4>Viral load (VL) monitoring is the standard of care in developing country settings for detecting HIV treatment failure. Since 2010 the World Health Organization has recommended a phase-in approach to VL monitoring in resource-limited settings. We conducted a systematic...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0085869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839609820551839744 |
|---|---|
| author | Kimberly A Sollis Pieter W Smit Susan Fiscus Nathan Ford Marco Vitoria Shaffiq Essajee David Barnett Ben Cheng Suzanne M Crowe Thomas Denny Alan Landay Wendy Stevens Vincent Habiyambere Jos Perrins Rosanna W Peeling |
| author_facet | Kimberly A Sollis Pieter W Smit Susan Fiscus Nathan Ford Marco Vitoria Shaffiq Essajee David Barnett Ben Cheng Suzanne M Crowe Thomas Denny Alan Landay Wendy Stevens Vincent Habiyambere Jos Perrins Rosanna W Peeling |
| author_sort | Kimberly A Sollis |
| collection | DOAJ |
| description | <h4>Background</h4>Viral load (VL) monitoring is the standard of care in developing country settings for detecting HIV treatment failure. Since 2010 the World Health Organization has recommended a phase-in approach to VL monitoring in resource-limited settings. We conducted a systematic review of the accuracy and precision of HIV VL technologies for treatment monitoring.<h4>Methods and findings</h4>A search of Medline and Embase was conducted for studies evaluating the accuracy or reproducibility of commercially available HIV VL assays. 37 studies were included for review including evaluations of the Amplicor Monitor HIV-1 v1.5 (n = 25), Cobas TaqMan v2.0 (n = 11), Abbott RealTime HIV-1 (n = 23), Versant HIV-1 RNA bDNA 3.0 (n = 15), Versant HIV-1 RNA kPCR 1.0 (n = 2), ExaVir Load v3 (n = 2), and NucliSens EasyQ v2.0 (n = 1). All currently available HIV VL assays are of sufficient sensitivity to detect plasma virus levels at a lower detection limit of 1,000 copies/mL. Bias data comparing the Abbott RealTime HIV-1, TaqMan v2.0 to the Amplicor Monitor v1.5 showed a tendency of the Abbott RealTime HIV-1 to under-estimate results while the TaqMan v2.0 overestimated VL counts. Compared to the Amplicor Monitor v1.5, 2-26% and 9-70% of results from the Versant bDNA 3.0 and Abbott RealTime HIV-1 differed by greater than 0.5log10. The average intra and inter-assay variation of the Abbott RealTime HIV-1 were 2.95% (range 2.0-5.1%) and 5.44% (range 1.17-30.00%) across the range of VL counts (2log10-7log10).<h4>Conclusions</h4>This review found that all currently available HIV VL assays are of sufficient sensitivity to detect plasma VL of 1,000 copies/mL as a threshold to initiate investigations of treatment adherence or possible treatment failure. Sources of variability between VL assays include differences in technology platform, plasma input volume, and ability to detect HIV-1 subtypes. Monitoring of individual patients should be performed on the same technology platform to ensure appropriate interpretation of changes in VL. Prospero registration # CD42013003603. |
| format | Article |
| id | doaj-art-4e95246e3d4b4fb79e8889ea5045d9db |
| institution | Matheson Library |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-4e95246e3d4b4fb79e8889ea5045d9db2025-07-30T05:31:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8586910.1371/journal.pone.0085869Systematic review of the performance of HIV viral load technologies on plasma samples.Kimberly A SollisPieter W SmitSusan FiscusNathan FordMarco VitoriaShaffiq EssajeeDavid BarnettBen ChengSuzanne M CroweThomas DennyAlan LandayWendy StevensVincent HabiyambereJos PerrinsRosanna W Peeling<h4>Background</h4>Viral load (VL) monitoring is the standard of care in developing country settings for detecting HIV treatment failure. Since 2010 the World Health Organization has recommended a phase-in approach to VL monitoring in resource-limited settings. We conducted a systematic review of the accuracy and precision of HIV VL technologies for treatment monitoring.<h4>Methods and findings</h4>A search of Medline and Embase was conducted for studies evaluating the accuracy or reproducibility of commercially available HIV VL assays. 37 studies were included for review including evaluations of the Amplicor Monitor HIV-1 v1.5 (n = 25), Cobas TaqMan v2.0 (n = 11), Abbott RealTime HIV-1 (n = 23), Versant HIV-1 RNA bDNA 3.0 (n = 15), Versant HIV-1 RNA kPCR 1.0 (n = 2), ExaVir Load v3 (n = 2), and NucliSens EasyQ v2.0 (n = 1). All currently available HIV VL assays are of sufficient sensitivity to detect plasma virus levels at a lower detection limit of 1,000 copies/mL. Bias data comparing the Abbott RealTime HIV-1, TaqMan v2.0 to the Amplicor Monitor v1.5 showed a tendency of the Abbott RealTime HIV-1 to under-estimate results while the TaqMan v2.0 overestimated VL counts. Compared to the Amplicor Monitor v1.5, 2-26% and 9-70% of results from the Versant bDNA 3.0 and Abbott RealTime HIV-1 differed by greater than 0.5log10. The average intra and inter-assay variation of the Abbott RealTime HIV-1 were 2.95% (range 2.0-5.1%) and 5.44% (range 1.17-30.00%) across the range of VL counts (2log10-7log10).<h4>Conclusions</h4>This review found that all currently available HIV VL assays are of sufficient sensitivity to detect plasma VL of 1,000 copies/mL as a threshold to initiate investigations of treatment adherence or possible treatment failure. Sources of variability between VL assays include differences in technology platform, plasma input volume, and ability to detect HIV-1 subtypes. Monitoring of individual patients should be performed on the same technology platform to ensure appropriate interpretation of changes in VL. Prospero registration # CD42013003603.https://doi.org/10.1371/journal.pone.0085869 |
| spellingShingle | Kimberly A Sollis Pieter W Smit Susan Fiscus Nathan Ford Marco Vitoria Shaffiq Essajee David Barnett Ben Cheng Suzanne M Crowe Thomas Denny Alan Landay Wendy Stevens Vincent Habiyambere Jos Perrins Rosanna W Peeling Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS ONE |
| title | Systematic review of the performance of HIV viral load technologies on plasma samples. |
| title_full | Systematic review of the performance of HIV viral load technologies on plasma samples. |
| title_fullStr | Systematic review of the performance of HIV viral load technologies on plasma samples. |
| title_full_unstemmed | Systematic review of the performance of HIV viral load technologies on plasma samples. |
| title_short | Systematic review of the performance of HIV viral load technologies on plasma samples. |
| title_sort | systematic review of the performance of hiv viral load technologies on plasma samples |
| url | https://doi.org/10.1371/journal.pone.0085869 |
| work_keys_str_mv | AT kimberlyasollis systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT pieterwsmit systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT susanfiscus systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT nathanford systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT marcovitoria systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT shaffiqessajee systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT davidbarnett systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT bencheng systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT suzannemcrowe systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT thomasdenny systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT alanlanday systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT wendystevens systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT vincenthabiyambere systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT josperrins systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples AT rosannawpeeling systematicreviewoftheperformanceofhivviralloadtechnologiesonplasmasamples |